Literature DB >> 10362898

Direct costs during the first year after intracerebral hemorrhage.

V Porsdal1, G Boysen.   

Abstract

OBJECTIVES: Knowledge of resource use and associated costs of treatment, care and rehabilitation at hospitals and in the health care and social service sectors is limited. This study presents data on the total resource use during the first year after spontaneous intracerebral hemorrhage.
METHODS: All patients hospitalized because of stroke at a university hospital in Copenhagen, Denmark, during a 1-year period 1994-1995 were included in a database. The patients were followed until 1 year after the stroke, and data on resource use during and after the hospital stay were collected prospectively. This study investigates a subgroup comprising 90 patients with intracerebral hemorrhage. Resource use is described and costs are calculated.
RESULTS: The cost of the hospital stay including acute care and rehabilitation had a mean of 90200 DKK (US$16100). The total cost of health care and social services during the first year had a mean of 123200 DKK (US$22000). Costs decreased significantly with age, but when differences of 30 days case fatality between age groups were considered, the association between costs and age disappeared.
CONCLUSIONS: The mean cost of treatment, care and rehabilitation during the first year after intracerebral hemorrhage was 123200 DKK, of which the primary hospital stay constituted 73%. Copyright 1999 Lippincott Williams & Wilkins

Entities:  

Mesh:

Year:  1999        PMID: 10362898     DOI: 10.1046/j.1468-1331.1999.640449.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  4 in total

1.  Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH): rationale and design.

Authors:  Adnan I Qureshi
Journal:  Neurocrit Care       Date:  2007       Impact factor: 3.210

2.  Estimating the lifetime economic burden of stroke according to the age of onset in South Korea: a cost of illness study.

Authors:  Hye-Young Kang; Seung-Ji Lim; Hae Sun Suh; Danny Liew
Journal:  BMC Public Health       Date:  2011-08-13       Impact factor: 3.295

Review 3.  Non-vitamin K antagonist oral anticoagulants and atrial fibrillation guidelines in practice: barriers to and strategies for optimal implementation.

Authors:  A John Camm; Fausto J Pinto; Graeme J Hankey; Felicita Andreotti; F D Richard Hobbs
Journal:  Europace       Date:  2015-07       Impact factor: 5.214

4.  Costs of major intracranial, gastrointestinal and other bleeding events in patients with atrial fibrillation - a nationwide cohort study.

Authors:  Marie Jakobsen; Christophe Kolodziejczyk; Eskild Klausen Fredslund; Peter Bo Poulsen; Lars Dybro; Søren Paaske Johnsen
Journal:  BMC Health Serv Res       Date:  2017-06-12       Impact factor: 2.655

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.